Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Liver cancer, adult primary
Stage/Subtype:  stage 0 adult primary liver cancer (BCLC)
Trial Type:  Treatment
Results 1-8 of 8 for your search:
Start Over
Gemcitabine Hydrochloride and Cisplatin with or without Radiation Therapy in Treating Patients with Localized Liver Cancer That Cannot Be Removed by Surgery
Status: Temporarily closed
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: NRG-GI001, NCI-2014-00849, PNRG-GI001_A01PAMDREVW01, PNRG-GI001_A02PAMDREVW01, NCT02200042
Chemoembolization with Doxorubicin Hydrochloride-Eluting Beads in Treating Patients with Liver Cancer Who Are Being Considered for Liver Transplant
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 124520, NCI-2015-00697, 082078, CC# 124520, DEB-TACE, UCSF CC#124520, NCT02147301
Gemcitabine Hydrochloride, Floxuridine, and Dexamethasone after Surgery in Treating Patients with Liver Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: 13-148, NCI-2013-01780, NCT01938729
Transarterial Chemoembolization With or Without Stereotactic Radiosurgery in Treating Patients With Liver Cancer Undergoing Liver Transplant
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 16213, NCI-2014-00406, 818180, UPCC 16213, NCT01918683
Gemcitabine Hydrochloride and Cisplatin before Surgery or Radiation Therapy in Treating Patients with Intrahepatic Bile Duct Cancer That Can or Cannot Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 14-275, NCI-2014-02362, NCT02256982
Individualized Adaptive Radiation Therapy in Treating Patients with Hepatocellular Carcinoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: UMCC 2015.039, NCI-2015-02158, HUM00098022, NCT02460835
MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients with Liver Metastases or Liver Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 15-000362, NCI-2015-01665, NCT02683200
Start Over